Related Experiment Video
Updated: Oct 23, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients
Jingrui Sui1,2, Denis F Noubouossie1, Sheetal Gandotra3
1Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Insights
Fibrinogen levels are often elevated in patients with coronavirus disease-19 (COVID-19), particularly those with severe illness. Elevated fibrinogen indicates increased inflammation and correlates with disease severity and intensive care unit (ICU) admission.
Area of Science:
- Infectious Diseases
- Hematology
- Critical Care Medicine
Background:
- Coronavirus disease-19 (COVID-19) presents with significant inflammation, cardiac issues, and coagulopathy.
- Fibrinogen, a key marker for inflammation, cardiovascular disease, and coagulation, requires further investigation in COVID-19.
- This study aimed to explore the clinical utility of fibrinogen in managing COVID-19 patients.
Purpose of the Study:
- To assess the clinical application of fibrinogen in COVID-19 patients.
- To investigate the correlation between fibrinogen levels and disease severity.
- To determine if fibrinogen can serve as a predictive biomarker for COVID-19 severity.
Main Methods:
- Retrospective analysis of 119 COVID-19 patients' demographic and laboratory data.
- Examined correlations between admission fibrinogen levels, ICU admission, and disease severity.
- Analyzed associations with other laboratory parameters, including cardiac biomarkers.
Main Results:
- Elevated fibrinogen was observed in 67.2% of patients, with higher levels in severe cases (P = 0.001).
- Fibrinogen levels significantly correlated with inflammatory markers and disease severity.
- An optimal fibrinogen cutoff of 528.0 mg/dl predicted severe disease with 66.7% sensitivity and 70.3% specificity (AUC 0.72).
Conclusions:
- Fibrinogen is frequently elevated in COVID-19 patients, especially those with severe disease.
- Elevated fibrinogen is linked to heightened inflammation, increased disease severity, and higher rates of ICU admission.
- Fibrinogen shows potential as a biomarker for predicting COVID-19 severity.
Background:
The coronavirus disease-19 (COVID-19) is characterized with intense inflammatory response, cardiac involvement, and coagulopathy. Fibrinogen, as a biomarker for inflammation, cardiovascular disease, and coagulation, has not been fully investigated yet. The aim of this study was to assess the clinical application of fibrinogen in COVID-19 patients.
Methods:
We retrospectively analyzed the demographic and laboratory characteristics of 119 COVID-19 patients in the University of Alabama of Birmingham Medical Center. Correlations of fibrinogen on admission with intensive care unit (ICU) admission, disease severity, and laboratory parameters were analyzed.
Results:
Among the 119 COVID-19 patients, 77.3% (92/119) had severe disease, and 59.5% (71/119) patients were admitted to the ICU. Elevated fibrinogen was detected in 67.2% (80/119) of the patients. Fibrinogen levels were significantly associated with inflammatory markers and disease severity, but not with cardiac injury biomarker high sensitivity troponin I. Patients with severe disease had increased fibrinogen levels upon admission compared to patients with non-severe disease (P = 0.001). Fibrinogen level at 528.0 mg/dl was the optimal cutoff to predict disease severity, with a sensitivity and specificity of 66.7% and 70.3% (area undty -60er the curve [AUC] 0.72, P = 0.0006).
Conclusions:
Fibrinogen is commonly elevated in COVID-19 patients, especially in those with severe disease. Elevated fibrinogen correlates with excessive inflammation, disease severity, and ICU admission in COVID-19 patients.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

